However, in contrast to mice dosed with the Mst3 ASO, Mst3–/– mice are also protected against the development of obesity-triggered systemic insulin resistance as demonstrated in the ITT and euglycemic–hyperinsulinemic clamp experiments [18]. This evidence concerns the gene STK24 and Insulin resistance.